Literature DB >> 22614130

The path from skin to brain: generation of functional neurons from fibroblasts.

Aisha Iman Abdullah1, Andrew Pollock, Tao Sun.   

Abstract

Cell fate reprogramming makes possible the generation of new cell types from healthy adult cells to replace those lost or damaged in disease. Additionally, reprogramming patient cells into specific cell types allows for drug screening and the development of new therapeutic tools. Generation of new neurons is of particular interest because of the potential to treat diseases of the nervous system, such as neurodegenerative disorders and spinal cord injuries, with cell replacement therapy. Recent advances in cell fate reprogramming have led to the development of novel methods for the direct conversion of fibroblasts into neurons and neural stem cells. This review will highlight the advantages of these new methods over neuronal induction from embryonic stem cells and induced pluripotent stem cells, as well as outline the limitations and the potential for future applications.

Entities:  

Mesh:

Year:  2012        PMID: 22614130      PMCID: PMC3564239          DOI: 10.1007/s12035-012-8277-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  93 in total

1.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

2.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.

Authors:  Wenlin Li; Wei Wei; Saiyong Zhu; Jinliang Zhu; Yan Shi; Tongxiang Lin; Ergeng Hao; Alberto Hayek; Hongkui Deng; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-12-18       Impact factor: 24.633

Review 4.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

5.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

6.  Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells.

Authors:  Joseph A Nielsen; Jo Ann Berndt; Lynn D Hudson; Regina C Armstrong
Journal:  Mol Cell Neurosci       Date:  2004-01       Impact factor: 4.314

7.  Hot spots of retroviral integration in human CD34+ hematopoietic cells.

Authors:  Claudia Cattoglio; Giulia Facchini; Daniela Sartori; Antonella Antonelli; Annarita Miccio; Barbara Cassani; Manfred Schmidt; Christof von Kalle; Steve Howe; Adrian J Thrasher; Alessandro Aiuti; Giuliana Ferrari; Alessandra Recchia; Fulvio Mavilio
Journal:  Blood       Date:  2007-05-16       Impact factor: 22.113

8.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Maurilio Ponzoni; Cynthia Bartholomae; Lucia Sergi Sergi; Fabrizio Benedicenti; Alessandro Ambrosi; Clelia Di Serio; Claudio Doglioni; Christof von Kalle; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2006-05-28       Impact factor: 54.908

9.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.

Authors:  Lei Cao; Lan Tan; Teng Jiang; Xi-Chen Zhu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.590

Review 2.  Integration of drug, protein, and gene delivery systems with regenerative medicine.

Authors:  Elizabeth R Lorden; Howard M Levinson; Kam W Leong
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 3.  Induced Stem Cells as a Novel Multiple Sclerosis Therapy.

Authors:  Chong Xie; Yan-Qun Liu; Yang-Tai Guan; Guang-Xian Zhang
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

Review 4.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

Review 5.  Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside.

Authors:  Maryam Parvini; Leila Satarian; Kazem Parivar; Mohammad Javan; Mahdi Tondar; Sajjad Ahmad; Hossein Baharvand
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

Review 6.  Tuning the cell fate of neurons and glia by microRNAs.

Authors:  Shan Bian; Tian-le Xu; Tao Sun
Journal:  Curr Opin Neurobiol       Date:  2013-08-23       Impact factor: 6.627

Review 7.  "Seq-ing" insights into the epigenetics of neuronal gene regulation.

Authors:  Francesca Telese; Amir Gamliel; Dorota Skowronska-Krawczyk; Ivan Garcia-Bassets; Michael G Rosenfeld
Journal:  Neuron       Date:  2013-02-20       Impact factor: 17.173

Review 8.  Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?

Authors:  Yuka Ikegame; Kentaro Yamashita; Shigeru Nakashima; Yuichi Nomura; Shingo Yonezawa; Yoshitaka Asano; Jun Shinoda; Hideaki Hara; Toru Iwama
Journal:  Front Cell Neurosci       Date:  2014-10-21       Impact factor: 5.505

Review 9.  Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.

Authors:  Xiao-hong Xu; Zhong Zhong
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

10.  Gene Signature of Human Oral Mucosa Fibroblasts: Comparison with Dermal Fibroblasts and Induced Pluripotent Stem Cells.

Authors:  Keiko Miyoshi; Taigo Horiguchi; Ayako Tanimura; Hiroko Hagita; Takafumi Noma
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.